Utility of BNP in Differentiating Constrictive Pericarditis from Restrictive Cardiomyopathy in Patients with Renal Insufficiency

Journal of Cardiac Failure

Volumn 13, Issue 8, 2007, Pages 668-671

  Reddy, Proddutur R ^a   Dieter, Robert S ^a   Das, Pranab ^a   Steen, Lowell H ^a   Lewis, Bruce E ^a   Leya, Ferdinand S ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain natriuretic peptide; constrictive pericarditis; renal insufficiency; restrictive cardiomyopathy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CONSTRICTIVE PERICARDITIS; DEMOGRAPHY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, RESTRICTIVE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PERICARDITIS, CONSTRICTIVE; RENAL INSUFFICIENCY;

EID: 34848905653     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.05.001     Document Type: Article

References (18)

1. Ha J.W., Ommen S.R., Tajik A.J., Barnes M.E., Ammash N.M., Gertz M.A., et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol 94 (2004) 316-319
2. Mertens L.L., Denef B., and De Geest H. The differentiation between restrictive cardiomyopathy and constrictive pericarditis: the impact of imaging techniques. Echocardiography 10 (1993) 497-508
3. Asher C.R., and Klein A.L. Diastolic heart failure: restrictive cardiomyopathy, constrictive pericarditis, and cardiac tamponade: clinical and echocardiographic evaluation. Cardiol Rev 10 (2002) 218-229
4. Oyama N., Oyama N., Komuro K., Nambu T., Manning W.J., and Miyasaka K. Computed tomography and magnetic resonance imaging of the pericardium: anatomy and physiology. Magn Reson Med Sci 3 (2004) 145-152
5. Rochitte C.E., Tassi E.M., and Shiozaki A.A. The emerging role of MRI in the diagnosis and management of cardiomyopathies. Curr Cardiol Rep 8 (2006) 44-52
6. Giorgi B., Mollet N.R., Dymarkowski S., Rademakers F.E., and Bogaert J. Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects. Radiology 228 (2003) 417-424
7. Leya F.S., Arab D., Joyal D., Shioura K.M., Lewis B.E., Steen L.H., et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 45 (2005) 1900-1902
8. Fonarow G.C., and Heywood J.T. The confounding issue of comorbid renal insufficiency. Am J Med 119 (2006) S17-S25
9. Tsutamoto T., Wada A., Sakai H., Ishikawa C., Tanaka T., Hayashi M., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47 (2006) 582-586
10. McCullough P.A., Kuncheria J., and Mathur V.S. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 5 (2004) 16-25
11. Babuin L., Alegria J.R., Oh J.K., Nishimura R.A., and Jaffe A.S. Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. J Am Coll Cardiol 47 (2006) 1489-1491
12. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
13. Takami Y., Horio T., Iwashima Y., Takiuchi S., Kamide K., Yoshihara F., et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 44 (2004) 420-428
14. Richards M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliot J., et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 47 (2006) 52-60
15. Luchner A., Hengstenberg C., Lowel H., Riegger G.A., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
16. Das S.R., Drazner M.H., Dries D.L., Vega G.L., Stanek H.G., Abdullah S.M., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 (2005) 2163-2168
17. Horwich T.B., Hamilton M.A., and Fonarow G.C. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47 (2006) 85-90
18. Ritz E., and Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. New Engl J Med 341 (1999) 1127-1133